Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci. 2008;28:407–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Massaly N, Copits BA, Wilson-Poe AR, Hipolito L, Markovic T, Yoon HJ, et al. Pain-induced negative affect is mediated via recruitment of the nucleus accumbens Kappa Opioid system. Neuron 2019;102:564–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quintanilla B, Medeiros GC, Greenstein D, Yuan P, Johnston JN, Park LT, et al. kappa-opioid receptor plasma levels are associated with sex and diagnosis of major depressive disorder but not response to ketamine. J Clin Psychopharmacol. 2023;43:89–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knoll AT, Carlezon WA Jr. Dynorphin, stress, and depression. Brain Res. 2010;1314:56–73.

Article  CAS  PubMed  Google Scholar 

Browne CA, Wulf H, Lucki I. Kappa opioid receptors in the pathology and treatment of major depressive disorder. Handb Exp Pharm. 2022;271:493–524.

Article  CAS  Google Scholar 

Karkhanis A, Holleran KM, Jones SR. Dynorphin/Kappa opioid receptor signaling in preclinical models of alcohol, drug, and food addiction. Int Rev Neurobiol. 2017;136:53–88.

Article  CAS  PubMed  Google Scholar 

Ozkan-Kotiloglu S, Kaya-Akyuzlu D, Yurdakul R, Yildirim MA, Ozgur-Ilhan I. Effect of PDYN and OPRK1 polymorphisms on the risk of alcohol use disorder and the intensity of depressive symptoms. Alcohol Alcohol. 2023;58:404–14.

Article  CAS  PubMed  Google Scholar 

Bazov I, Kononenko O, Watanabe H, Kuntic V, Sarkisyan D, Taqi MM, et al. The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction. Addict Biol. 2013;18:161–9.

Article  CAS  PubMed  Google Scholar 

Vijay A, Cavallo D, Goldberg A, de Laat B, Nabulsi N, Huang Y, et al. PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age. Neuropsychopharmacology 2018;43:2539–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marinelli PW, Lam M, Bai L, Quirion R, Gianoulakis C. A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res. 2006;30:982–90.

Article  CAS  PubMed  Google Scholar 

Niinep K, Anier K, Etelainen T, Piepponen P, Kalda A. Repeated ethanol exposure alters DNA methylation status and Dynorphin/Kappa-Opioid receptor expression in nucleus accumbens of alcohol-preferring AA rats. Front Genet. 2021;12:750142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosin A, Lindholm S, Franck J, Georgieva J. Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. Neurosci Lett. 1999;275:1–4.

Article  CAS  PubMed  Google Scholar 

Erikson CM, Wei G, Walker BM. Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis. Neuropharmacology 2018;140:162–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosin A, Lindholm S, Franck J, Georgieva. Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. Neurosci Lett. 1999;275:1–4.

Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol. 2008;59:29–53.

Article  PubMed  Google Scholar 

Pirino BE, Kelley AM, Karkhanis AN, Barson JR. A critical review of effects on ethanol intake of the dynorphin/kappa opioid receptor system in the extended amygdala: From inhibition to stimulation. Alcohol (Hanover). 2023;47:1027–38.

CAS  Google Scholar 

Glockner-Rist A, Lemenager T, Mann K, Group PSR. Reward and relief craving tendencies in patients with alcohol use disorders: results from the PREDICT study. Addict Behav. 2013;38:1532–40.

Article  PubMed  Google Scholar 

Roos CR, Mann K, Witkiewitz K. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone. Addict Biol. 2017;22:1528–39.

Article  CAS  PubMed  Google Scholar 

Walker BM, Zorrilla EP, Koob GF. Systemic kappa-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol. 2011;16:116–9.

Article  CAS  PubMed  Google Scholar 

Anderson RI, Lopez MF, Griffin WC, Haun HL, Bloodgood DW, Pati D, et al. Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice. Neuropsychopharmacology 2019;44:1084–92.

Article  CAS  PubMed  Google Scholar 

Karkhanis AN, Rose JH, Weiner JL, Jones SR. Early-life social isolation stress increases Kappa opioid receptor responsiveness and downregulates the dopamine system. Neuropsychopharmacology 2016;41:2263–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rose JH, Karkhanis AN, Chen R, Gioia D, Lopez MF, Becker HC, et al. Supersensitive Kappa opioid receptors promotes ethanol withdrawal-related behaviors and reduce dopamine signaling in the nucleus accumbens. Int J Neuropsychopharmacol. 2016;19:5.

Article  Google Scholar 

Morales M, Anderson RI, Spear LP, Varlinskaya EI. Effects of the kappa opioid receptor antagonist, nor-binaltorphimine, on ethanol intake: impact of age and sex. Dev Psychobiol. 2014;56:700–12.

Article  CAS  PubMed  Google Scholar 

Pirino BE, Martin CR, Carpenter BA, Curtis GR, Curran-Alfaro CM, Samels SB, et al. Sex-related differences in pattern of ethanol drinking under the intermittent-access model and its impact on exploratory and anxiety-like behavior in Long-Evans rats. Alcohol Clin Exp Res. 2022;46:1282–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995;18:22–9.

Article  CAS  PubMed  Google Scholar 

Castro DC, Bruchas MR. A motivational and neuropeptidergic hub: anatomical and functional diversity within the nucleus accumbens shell. Neuron 2019;102:529–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nealey KA, Smith AW, Davis SM, Smith DG, Walker BM. kappa-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats. Neuropharmacology 2011;61:35–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barson JR, Carr AJ, Soun JE, Sobhani NC, Leibowitz SF, Hoebel BG. Opioids in the nucleus accumbens stimulate ethanol intake. Physiol Behav. 2009;98:453–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uhari-Vaananen J, Raasmaja A, Backstrom P, Oinio V, Airavaara M, Piepponen P, et al. Accumbal mu-opioid receptors modulate ethanol intake in alcohol-preferring alko alcohol rats. Alcohol Clin Exp Res. 2016;40:2114–23.

Article  PubMed  Google Scholar 

Al-Hasani R, McCall JG, Shin G, Gomez AM, Schmitz GP, Bernardi JM, et al. Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward. Neuron 2015;87:1063–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castro DC, Berridge KC. Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness "liking" and "wanting". J Neurosci. 2014;34:4239–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pirino BE, Spodnick MB, Gargiulo AT, Curtis GR, Barson JR, Karkhanis AN. Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis. Neuropharmacology 2020;181:108341.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Endoh T, Matsuura H, Tanaka C, Nagase H. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther. 1992;316:30–42.

CAS  PubMed  Google Scholar 

Birch PJ, Hayes AG, Sheehan MJ, Tyers MB. Norbinaltorphimine: antagonist profile at kappa opioid receptors. Eur J Pharm. 1987;144:405–8.

Article  CAS  Google Scholar 

Munro TA, Berry LM, Van't Veer A, Beguin C, Carroll FI, Zhao Z, et al. Long-acting kappa opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity. BMC Pharm. 2012;12:5.

Article  CAS  Google Scholar 

Grimm JW, North K, Hopkins M, Jiganti K, McCoy A, Sulc J, et al. Sex differences in sucrose reinforcement in Long-Evans rats. Biol Sex Differ. 2022;13:3.

Article  CAS  PubMed